Equities Analysts Offer Predictions for STERIS Q3 Earnings

STERIS plc (NYSE:STE - Free Report) - Stock analysts at Zacks Research boosted their Q3 2025 earnings per share estimates for shares of STERIS in a research note issued to investors on Tuesday, December 24th. Zacks Research analyst R. Department now forecasts that the medical equipment provider will post earnings per share of $2.30 for the quarter, up from their prior forecast of $2.29. The consensus estimate for STERIS's current full-year earnings is $9.10 per share. Zacks Research also issued estimates for STERIS's Q4 2025 earnings at $2.60 EPS, FY2025 earnings at $9.07 EPS, Q1 2026 earnings at $2.25 EPS, Q3 2026 earnings at $2.50 EPS, FY2026 earnings at $9.92 EPS, Q1 2027 earnings at $2.47 EPS and FY2027 earnings at $10.25 EPS.

Other research analysts have also recently issued reports about the stock. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Friday, November 8th. Stephens reiterated an "overweight" rating and issued a $260.00 price target on shares of STERIS in a research note on Thursday, November 7th. KeyCorp upped their price objective on STERIS from $255.00 to $265.00 and gave the stock an "overweight" rating in a research report on Tuesday, September 3rd. JMP Securities reaffirmed a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Monday, November 18th. Finally, StockNews.com downgraded STERIS from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, October 29th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, STERIS has an average rating of "Moderate Buy" and a consensus target price of $262.50.

STERIS Price Performance

Shares of NYSE:STE traded down $0.74 during midday trading on Friday, hitting $207.98. The stock had a trading volume of 268,940 shares, compared to its average volume of 503,285. The company's 50-day moving average price is $217.49 and its 200-day moving average price is $226.11. STERIS has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $20.53 billion, a P/E ratio of 47.48 and a beta of 0.83.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.12 by $0.02. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. STERIS's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.03 EPS.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th were issued a $0.57 dividend. The ex-dividend date was Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.10%. STERIS's payout ratio is presently 52.05%.

Insider Buying and Selling at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the business's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.14% of the company's stock.

Hedge Funds Weigh In On STERIS

Several large investors have recently modified their holdings of STE. Franklin Resources Inc. increased its stake in shares of STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after buying an additional 529,308 shares during the period. Tidal Investments LLC boosted its holdings in STERIS by 21.0% in the third quarter. Tidal Investments LLC now owns 12,650 shares of the medical equipment provider's stock valued at $3,068,000 after acquiring an additional 2,193 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in STERIS during the 3rd quarter valued at approximately $9,949,000. World Investment Advisors LLC bought a new position in STERIS during the 3rd quarter worth approximately $5,171,000. Finally, SkyView Investment Advisors LLC raised its holdings in STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after purchasing an additional 51 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.